UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Strategy Inc
MSTR
|
+$1.21B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$855M |
| 3 |
Microsoft
MSFT
|
+$810M |
| 4 |
Advanced Micro Devices
AMD
|
+$805M |
| 5 |
Boeing
BA
|
+$739M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$561M |
| 2 |
Amneal Pharmaceuticals
AMRX
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$161M |
| 4 |
Unity
U
|
+$158M |
| 5 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.49% |
| 2 | Financials | 9.06% |
| 3 | Consumer Discretionary | 7.01% |
| 4 | Healthcare | 6.25% |
| 5 | Industrials | 6.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6876
Empire Petroleum
EP
$111M
| $96.7K | ﹤0.01% |
12,726
+5,319
| +72% | +$31.5K |
|
6877
BioVie
BIVI
$7.54M
| $96.7K | ﹤0.01% |
4,833
+4,828
| +96,560% | +$116K |
|
|
CYPH
6878
Cypherpunk Technologies Inc
CYPH
$73.3M
| $96.4K | ﹤0.01% |
33,534
+33,463
| +47,131% | +$99.4K |
|
6879
Alpha Architect US Quantitative Value ETF
QVAL
$605M
| $96.4K | ﹤0.01% |
+2,159
| New | +$99.1K |
|
|
CNTN
6880
Canton Strategic Holdings
CNTN
$144M
| $96.4K | ﹤0.01% |
+47,465
| New | +$107K |
|
|
HLVX
6881
DELISTED
HilleVax
HLVX
| $96.3K | ﹤0.01% |
46,503
+29,597
| +175% | +$55.6K |
|
6882
Orchestra BioMed
OBIO
$254M
| $96.3K | ﹤0.01% |
24,065
+12,583
| +110% | +$67.6K |
|
|
FDIQ
6883
Invesco Bloomberg Financial Data Providers ETF
FDIQ
$50.6M
| $96.1K | ﹤0.01% |
1,607
-3,823
| -70% | -$235K |
|
|
ESSA
6884
DELISTED
ESSA Bancorp
ESSA
| $95.9K | ﹤0.01% |
4,917
+485
| +11% | +$9.51K |
|
|
OACCU
6885
Oaktree Acquisition Corp III Life Sciences Unit
OACCU
| $95.9K | ﹤0.01% |
+9,483
| New | +$95.5K |
|
6886
T. Rowe Price Equity Income ETF
TEQI
$470M
| $95.7K | ﹤0.01% |
2,359
+2,129
| +926% | +$89.4K |
|
|
AMZE
6887
Amaze Holdings
AMZE
$1.48M
| $95.5K | ﹤0.01% |
892
+833
| +1,412% | +$114K |
|
|
IGTR
6888
DELISTED
Innovator Gradient Tactical Rotation Strategy ETF
IGTR
| $95.2K | ﹤0.01% |
3,879
+3,561
| +1,120% | +$93.3K |
|
|
SPE
6889
Special Opportunities Fund
SPE
$144M
| $95.1K | ﹤0.01% |
6,807
-1,334
| -16% | -$18.8K |
|
6890
Valhi
VHI
$450M
| $94.8K | ﹤0.01% |
4,055
+2,903
| +252% | +$86.2K |
|
6891
BeyondSpring
BYSI
$35.8M
| $94.7K | ﹤0.01% |
58,091
+51,710
| +810% | +$102K |
|
|
ETH
6892
Grayscale Ethereum Staking Mini ETF Shares
ETH
$1.75B
| $94.6K | ﹤0.01% |
+3,004
| New | +$87.1K |
|
|
PLRZ
6893
Polyrizon Ltd
PLRZ
$24.2M
| $94.1K | ﹤0.01% |
+29
| New | +$55.2K |
|
6894
Stereotaxis
STXS
$141M
| $93.8K | ﹤0.01% |
41,147
+28,504
| +225% | +$59.6K |
|
6895
VanEck India Growth Leaders ETF
GLIN
$95.5M
| $93.7K | ﹤0.01% |
+1,905
| New | +$99.4K |
|
|
SPLP
6896
DELISTED
STEEL PARTNERS HOLDINGS L.P.
SPLP
| $93.5K | ﹤0.01% |
2,197
-487
| -18% | -$20K |
|
|
NTRL
6897
First Trust Equity Market Neutral ETF
NTRL
$16.2M
| $93.4K | ﹤0.01% |
+4,698
| New | +$93K |
|
6898
authID Inc
AUID
$10.6M
| $93.4K | ﹤0.01% |
15,507
+7,937
| +105% | +$52.8K |
|
6899
Pioneer Bancorp
PBFS
$434M
| $93.2K | ﹤0.01% |
8,089
+2,593
| +47% | +$29.5K |
|
6900
ESS Tech
GWH
$18.9M
| $92.9K | ﹤0.01% |
+15,799
| New | +$105K |
|
Similar funds
UBS Group's Q4 2024 Portfolio in Review
As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.
- UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
- UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
- UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
- UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
- UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
- UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.
Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.